BlackRock’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $10.8M | Buy |
|
|||||
|
2025
Q2 | $7.83M | Buy |
|
|||||
|
2025
Q1 | $2.08M | Buy |
|
|||||
|
2024
Q4 | $3.12M | Sell |
|
|||||
|
2024
Q3 | $1.97M | Sell |
|
|||||
|
2024
Q2 | $2.24M | Sell |
|
|||||
|
2024
Q1 | $6.45M | Sell |
|
|||||
|
2023
Q4 | $6.2M | Buy |
|
|||||
|
2023
Q3 | $38.4M | Buy |
|
|||||
|
2023
Q2 | $58M | Buy |
|
|||||
|
2023
Q1 | $41.4M | Buy |
|
|||||
|
2022
Q4 | $80.1M | Buy |
|
|||||
|
2022
Q3 | $75.7M | Buy |
|
|||||
|
2022
Q2 | $65.2M | Buy |
|
|||||
|
2022
Q1 | $68.7M | Sell |
|
|||||
|
2021
Q4 | $59.3M | Buy |
|
|||||
|
2021
Q3 | $68.2M | Buy |
|
|||||
|
2021
Q2 | $56.9M | Buy |
|
|||||
|
2021
Q1 | $24.8M | Buy |
|
|||||
|
2020
Q4 | $6.3M | Sell |
|
|||||
|
2020
Q3 | $2.67M | Sell |
|
|||||
|
2020
Q2 | $1.7M | Sell |
|
|||||
|
2020
Q1 | $2.73M | Sell |
|
|||||
|
2019
Q4 | $4.99M | Sell |
|
|||||
|
2019
Q3 | $3.27M | Buy |
|
|||||
|
2019
Q2 | $6.53M | Sell |
|
|||||
|
2019
Q1 | $18.8M | Sell |
|
|||||
|
2018
Q4 | $26.8M | Buy |
|
|||||
|
2018
Q3 | $36.6M | Buy |
|
|||||
|
2018
Q2 | $46.2M | Buy |
|
|||||
|
2018
Q1 | $36.9M | Sell |
|
|||||
|
2017
Q4 | $54.1M | Buy |
|
|||||
|
2017
Q3 | $44.1M | Buy |
|
|||||
|
2017
Q2 | $32.5M | Buy |
|
|||||
|
2017
Q1 | $23.3M | Buy |
|
|||||
|
2016
Q4 | $19K | Buy |
|
|||||
|
2016
Q3 | $13K | Sell |
|
|||||
|
2016
Q2 | $16K | Buy |
|
|||||
|
2016
Q1 | $7K | Buy |
|